Jane Street’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Jane Street's ADPT Position: Q2 2026 in Review
Jane Street increased its Adaptive Biotechnologies (ADPT) stake by 133% in Q2 2026, buying an estimated $13.9M and bringing the position to 1,590,513 shares worth $34.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.
Jane Street first reported a position in ADPT in Q1 2020 and has held it in 23 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Jane Street held 1,590,513 shares of Adaptive Biotechnologies worth $34.1M as of Q2 2026.
- Jane Street bought 908,331 Adaptive Biotechnologies shares in Q2 2026, an estimated $13.9M.
- Adaptive Biotechnologies made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1700 holding.
- Jane Street first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 23 quarters since.
- 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.